An interventional study of ACP oral care gel and glycrin in Tooth Bleaching, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-09-18.
Sponsored by Cairo University · Not applicable, Interventional, and Other
Evaluating the effect of a desensitizing agent on post-bleaching hypersensitivity.
A randomized clinical trail will be done to evaluate the effect of a desensitizing agent ACP oral care gel in comparison to a control group on hypersensitivity after bleaching using a visual analogue scale.
1,916 studies on the registry are indexed under Hypersensitivity; 265 are open to participants now.
This study's enrollment of 36 is below the median of 57 across 1,384 interventional studies indexed under Hypersensitivity.
Browse Hypersensitivity studies →Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.
Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
a desensitizing agent will be applied on tooth before and /or after bleaching.
Other: ACP oral care gel
glycrin will be applied on tooth before and /or after bleaching.
Other: glycrin
a desensitizing agent will be applied on tooth before and/or after bleaching
glycrin will be applied on tooth surface before and/or after bleaching
Post-bleaching hypersensitivity assessed using visual analogue scale
using visual analogue scale
Time frame: one month
Tooth color assessed using value-ordered VITA® Classical Shade Guide
value-ordered VITA® Classical Shade Guide
Time frame: one month
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cairo University